Fixing the filler problem
NewsPosted by: Dental Design 8th November 2019
Leo Briggs, Deputy Head of the DDU, discusses the legal and ethical implications of providing cosmetic treatments.
Non-surgical cosmetic interventions have increased in popularity over recent years and many dental professionals provide or are considering providing treatments such as dermal fillers.
Tighter regulation of providers of cosmetic treatment such as botulinum toxin and dermal fillers has been brought in with the establishment in March 2018 of the Joint Council for Cosmetic Practitioners (JCCP)’s voluntary register of practitioners. The JCCP self-regulates providers, including dentists and has a memorandum of understanding with the GDC to share certain information. The body publishes a code of conduct, and has introduced measures to protect those who may be seeking treatment because of an underlying mental health issue such as body dysmorphic disorder.
Given the risks inherent in providing botulinum toxin, dermal fillers and similar treatments, it is essential that dental professionals are aware of the legal and ethical implications explained below.
Ethical requirements
The GDC expects dental professionals to be trained, competent and to meet its ethical standards in any treatment they carry out. This includes obtaining appropriate consent, explaining the cost and ensuring patients are able to make a complaint.
Training and qualifications
The GDC’s Scope of Practice includes ‘providing non-surgical cosmetic injectables’ as an additional skill that a dentist can acquire post-qualification.
Make sure you’ve had the necessary training to meet your individual needs from a reputable training provider. The JCCP has a register of approved education and training providers.
Prescribing
In its guidance on prescribing medicines, the GDC states ‘you must only prescribe medicines to meet the identified dental needs of your patients’.
Botulinum toxin is a prescription-only medicine (although dermal fillers are not) and is not considered suitable for prescription under a patient group direction. As a prescriber, the dentist would generally need to make a full assessment of the patient and accept responsibility for them.
The GDC states that dentists ‘must not remote prescribe (for example via telephone, email, or a website) for non-surgical cosmetic procedures such as the prescription or administration of Botox or injectable cosmetic medicinal products.’
Marketing
In line with GDC Standard 1.3.3, it’s important to avoid any offer or claim which could be seen as misleading. Patients also need to give consent for the use of their confidential information in marketing material, which should be both contemporaneous and specific. This includes photographs and testimonials.
All marketing material must also conform to the code published by the Committee of Advertising Practice (CAP). The Advertising Standards Authority (ASA), which enforces the Code, can demand the withdrawal of adverts which do not conform.
Under the Human Medicines Regulations (2012) you’re not allowed to advertise or promote a prescription-only medicine, so rather than using ‘Botox’ or ‘botulinum toxin’ in marketing material, you can instead refer to ‘facial cosmetic treatment’ or ‘anti-wrinkle treatment’.
Indemnity
Check with your indemnity provider about membership benefits. As far as the DDU is concerned, we offer access to indemnity for dentists (but not dental therapists or hygienists) undertaking injections of botulinum toxin and FDA approved dermal fillers in the face, but not in the neck or anywhere else in the body.
Dentists who want to offer these types of cosmetic treatments should contact their dental defence organisation for more information.








